Literature DB >> 22751171

Prevention of Alzheimer's disease: moving backward through the lifespan.

Alina Solomon1, Miia Kivipelto, Hilkka Soininen.   

Abstract

This is a brief summary of experiences from Finland related to Alzheimer's disease (AD) prevention research. The first signals that AD may have vascular modifiable risk factors came from studies on cardiovascular conditions and diabetes. Cardiovascular prevention projects such as North Karelia Project and WHO-MONICA in the 1970-1980 s were focused on younger populations, which led to the idea of looking for risk factors as far back as middle age. Cardiovascular Risk Factors, Aging and Incidence of Dementia (CAIDE) is one of the few studies in the world focusing on late-life cognition with a large and representative population-based cohort, baseline examination at midlife, and follow-up time up to three decades. Since 1998, it has identified several modifiable risk factors for cognitive impairment/dementia, and produced the first risk score for estimating dementia risk based on midlife profiles. The CAIDE Dementia Risk Score has been used to select participants in the Finnish Geriatric Intervention Study to prevent cognitive impairment and disability (FINGER). FINGER is an ongoing multicenter RCT involving 1,200 participants aged 60-77 years, and testing the effects of a two-year multi-domain intervention targeting several risk factors simultaneously. It started in September 2009 and will be completed at the end of 2013. The FINGER study is at the forefront of international collaborative efforts to solve the clinical and public health problems of early identification of individuals at increased risk of late-life cognitive impairment, and of developing intervention strategies to prevent or delay the onset of cognitive impairment and dementia.

Entities:  

Mesh:

Year:  2013        PMID: 22751171     DOI: 10.3233/JAD-2012-129021

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  10 in total

1.  Association of OGG1 and DLST promoter methylation with Alzheimer's disease in Xinjiang population.

Authors:  Wei Chen; Xiaohui Zhou; Yali Duan; Ting Zou; Guili Liu; Xiuru Ying; Qinwen Wang; Shiwei Duan
Journal:  Exp Ther Med       Date:  2018-07-26       Impact factor: 2.447

2.  Use of biomarkers and imaging to assess pathophysiology, mechanisms of action and target engagement.

Authors:  H Hampel; S Lista
Journal:  J Nutr Health Aging       Date:  2013-01       Impact factor: 4.075

Review 3.  Sex and gender differences in the causes of dementia: a narrative review.

Authors:  Walter A Rocca; Michelle M Mielke; Prashanthi Vemuri; Virginia M Miller
Journal:  Maturitas       Date:  2014-05-27       Impact factor: 4.342

4.  History and experience: a survey of traditional chinese medicine treatment for Alzheimer's disease.

Authors:  Ping Liu; Mingwang Kong; Shihe Yuan; Junfeng Liu; Ping Wang
Journal:  Evid Based Complement Alternat Med       Date:  2014-01-29       Impact factor: 2.629

5.  Validity and reliability of the Brazilian Portuguese version of the Australian National University - Alzheimer's Disease Risk Index (ANU-ADRI).

Authors:  Marcus Kiiti Borges; Alessandro Ferrari Jacinto; Vanessa Albuquerque Citero
Journal:  Dement Neuropsychol       Date:  2018 Jul-Sep

6.  Participant Perspectives of Cognitive Rehabilitation for Type 2 Diabetes: Expectations and Impact.

Authors:  Heather E Cuevas; Alexa K Stuifbergen; Catherine Ward
Journal:  J Aging Res       Date:  2018-08-19

7.  Intellectual engagement and cognitive ability in later life (the "use it or lose it" conjecture): longitudinal, prospective study.

Authors:  Roger T Staff; Michael J Hogan; Daniel S Williams; L J Whalley
Journal:  BMJ       Date:  2018-12-10

8.  Third follow-up of the Cardiovascular Risk Factors, Aging and Dementia (CAIDE) cohort investigating determinants of cognitive, physical, and psychosocial wellbeing among the oldest old: the CAIDE85+ study protocol.

Authors:  Mariagnese Barbera; Jenni Kulmala; Inna Lisko; Eija Pietilä; Anna Rosenberg; Ilona Hallikainen; Merja Hallikainen; Tiina Laatikainen; Jenni Lehtisalo; Elisa Neuvonen; Minna Rusanen; Hilkka Soininen; Jaakko Tuomilehto; Tiia Ngandu; Alina Solomon; Miia Kivipelto
Journal:  BMC Geriatr       Date:  2020-07-10       Impact factor: 3.921

9.  Cerebrovascular amyloid Angiopathy in bioengineered vessels is reduced by high-density lipoprotein particles enriched in Apolipoprotein E.

Authors:  Jerome Robert; Emily B Button; Emma M Martin; Luke McAlary; Zoe Gidden; Megan Gilmour; Guilaine Boyce; Tara M Caffrey; Andrew Agbay; Amanda Clark; Judith M Silverman; Neil R Cashman; Cheryl L Wellington
Journal:  Mol Neurodegener       Date:  2020-03-25       Impact factor: 14.195

10.  Preparation of the particles of Acanthopanax senticosus.

Authors:  Miao Yu; Bing Wang; An'na Qiao; Yubin Ji
Journal:  Saudi J Biol Sci       Date:  2019-07-15       Impact factor: 4.219

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.